January 1, 2025

Mastering CMS regulations: How to ensure a finding-free Joint Commission survey

By: Uyen Vo, BSN, MBA
Share

Takeaways

• Requirements for improvement and condition level deficiency findings have been trending up in recent The Joint Commission surveys.

• The scoring trends and OR hot spots focus on infection control, medication management, national patient safety goals, post-surgical electronic health record tracers, and transplant (tissue) safety.

• Federal regulations, manufacturer’s instructions for use, and national guidelines of best clinical practices should serve as the basis for policies and procedures that are easy for staff to understand and follow.


John Rosing, MHA, FACHE

With capability to bill Medicare and Medicaid hanging in the balance, quality and safety surveys from The Joint Commission (TJC) can be nerve-racking for hospitals and surgical facilities. In an hours-long workshop at the 2024 OR Manager Conference, John Rosing, MHA, FACHE, identified a number of specific “hot spots”: areas where ORs and surgical centers are likely to get into trouble.

Leveraging his experience as executive vice president and principal at Patton Healthcare Consulting (an affiliate of HBS of Langhorne, Pennsylvania), Rosing also offered tips on how to conduct a self-evaluation by “seeing with the surveyor’s eyes,” particularly for issues involving central sterile processing and high-level disinfection (HLD).

 

OR hot spots

Quality and safety standards evaluated by TJC surveys are predicated largely on the Centers for Medicare & Medicaid Services (CMS) Conditions of Participation (CoP). The latest data indicates a rise in requirements for improvement (RFIs) as well as condition-level deficiencies documented by surveyors from 2023 to 2024 (sidebar, Current scoring trends). Areas of particular concern include the following:

• Medication management. Examples of citations related to this issue include:

❯ Unlabeled medication. This is a frequently scored item, particularly for syringes on unattended anesthesia carts.

❯ Anesthesia cart maintenance. The cart must be secured, and single-use vials must be used as indicated (one needle, one syringe, and only one-time use.)

❯ Medication security. Providers must define who is authorized to access non-controlled medication.

❯ Medication temperature monitoring. Surgical facilities must take action (and document actions taken) in response to “temperature excursions.”

❯ Inspection and maintenance of malignant hyperthermia carts. This should occur daily, using tamper-tell plastic locks and verifying cart location, lock integrity, and first-to-expire date. Carts kept in centralized storage should be easily retrievable in less than 10 minutes.

• National Patient Safety Goals (NPSGs). Created by TJC in 2003 to reduce preventable harm to patients, these safety standards encompass a number of hot spots for surgical centers. For example, the goal of properly identifying patients could be compromised by hand-off communication breakdowns, lack of standards for naming newborns or multiples, or not labeling specimens in a patient’s presence. Other examples of NPSG pitfalls include:

❯ Failing to label solutions on the sterile field (NPSG.04.01).

❯ Failing to follow evidence-based clinical practice guidelines for anti-coagulant management (NPSG.03.05.01).

❯ Lacking clear protocols for setting and responding to clinical alarms (NPSG.06.01.01).

❯ Medical reconciliation problems resulting from not identifying discrepancies among a home medication list, the admission medication list, and the list of hospital-prescribed medications (NPSG.03.06.01).

❯ Citations related to the universal protocol, such as un-meticulous pre-procedure timeouts or inadequate fire prevention protocol (UP.01.01.01).

• Post-surgical electronic health record (EHR) tracer. Is the history and physical (H&P) report (or an update) less than 30 days old, and does it meet CMS requirements? Does preanesthesia assessment adhere to American Society of Anesthesiologists (ASA) guidelines? Did the time-out happen prior to incision with all participants involved? Was the postanesthesia assessment performed within 48 hours? All of these questions and more are likely to be on the table. Common documents surveyors want to see include the H&P, the preanesthesia assessment, the time-out, and the postanesthesia assessment.

• Transplant tissue safety. This is not a new or top-scored issue, but it is increasingly scored. Hospitals must be vigilant to address the following issues associated with TJC standard TS.03.01.01:

❯ Confirming tissue suppliers are registered and licensed (see the Food and Drug Administration [FDA] registration in References).

❯ Logging all received tissues and verifying package integrity upon receipt.

❯ Properly maintaining and monitoring storage equipment.

❯ Adhering to prohibitions on shipping tissues to other hospitals (although delivering to surgical suites across campus may be allowed).

Other potential hot spots relate to TS.03.02.01, including:

❯ Recording bidirectional tracing of tissues back to the manufacturer (in receipt and storage) and to the patient.

❯ Identifying in writing the materials and instructions for when tissue is accepted, prepared, and issued, including lot numbers and manufacturers of any fluid used to reconstitute in case of a recall.

❯ Recording the tissue and tissue ID in the medical records.

❯ Maintaining patient records for at least 10 years (including temperatures, procedures, manuals, and product inserts).

Thinking like a surveyor

The best way to prepare for a survey is to perform a self-assessment with the Hospital Accreditation Survey Activity Guide, Rosing says. Focusing on processes surrounding sterile processing and high-level disinfection, the following recommendations cover what to inspect and ask about in the following areas:

• Air pressure, environment. Air pressure must be positive into clean spaces and negative into dirty spaces—that is, negative into decontamination (Decontam) and positive from prep & pack and instrument storage to outside areas. All of central sterile should be clean (no grime or sticky stuff on surfaces, no standing water or insects in light fixtures) and in compliance with industry standards, such as AAMI requirements against particulate or fiber-shedding ceiling tiles. Eye-wash stations must be easily accessible and in good working order, with correct temperature (a tepid 60–100F) and pressure.

Questions to ask include:

❯ What is the process for documenting temperature, humidity, and air pressure?

❯ How often is terminal cleaning performed in central sterilization and decontam?

❯ Is there instructional signage for using the eye-wash station? Are protective caps in place—and does the force of the water dislodge them?

• Prep and pack. Good lighting and cleanliness are critical. Blue wrap is particularly prone to collecting dust. Magnification, borescopes, and other equipment must be in good working condition. Different sterilization wrap models have different weight recommendations for different instruments, and facilities need to follow manufacturer’s instructions for use (MIFUs). The surveyor may do a tracer on a package and weigh an item to see if it follows MIFUs.

Questions to ask include:

❯ How are instruments inspected, and what indicates they are clean? What is the process for removing an instrument from the sterilization process if it is unfit for use?

❯ Who cleans workstations and how often? What about dusting the overhead lights?

❯ Are blue wraps stored and used properly?

❯ Are trays weighed? Are there MIFUs? Does the scale work?

• Sterilizer and instrument condition. Preventative maintenance and cleaning schedules should be up-to-date for all sterilizers. Other checks include ensuring rubber seals are not damaged and that there are no stickers or debris on the sterilizer. As for instruments, TJC Quick Safety Issue 64, February 2022, specifies inspecting for soil or damage “including but not limited to bioburden, oxidation, corrosion, pitting, discoloration, cracking, peeling, chipping, lifting or improperly applied identification tape, or etching that leaves rough or frayed edges.”

Questions to ask include:

❯ Are insulation testing units in working order? Are instrument ID tapes or tag labels intact and easy to read?

❯ Are single-use items—which usually have a “do not sterilize” warning and no MIFU for sterilization—always treated as such?

• Sterilization monitoring. Safety demands robust processes for monitoring and documenting sterilization efficacy, temperature, time, and pressure. Rosing emphasizes the following:

❯ Biologicals and controls. Self-surveys should verify that biologicals match the sterilization method (eg, steam or low-temperature) and the cycle (eg, prevac or gravity), and that biologicals and controls are from the same lot. Other checks include whether MIFUs are available for biologicals and for compliance with hospital policy, which might require biological control with each load. Additionally, AAMI ST79 covers using biological indicators (13.5.3.2) and controls (13.7.2.4:5) in cycle testing (13.7.1), implants (13.5.3.2), and sterilization repairs (13.5.3.2).

❯ Bowie-Dick checks. Daily checks of an empty steam sterilizer (before the first processed load) can ensure the efficacy of air removal and steam penetration.

❯ Chemical indicators. Different chemical indicators for different sterilization methods can be placed inside or outside the item being monitored. Following the MIFU ensures accuracy and quality. AAMI ST79 also addresses external and internal chemical indicators (13.5.2.2.1 and 13.5.2.2.2).

Whatever the testing method, each cycle should be documented according to AAMI ST79: 13.3.3. Specific records include load number, contents, exposure time/temperature, operator identification, biological results (if applicable), Bowie-Dick results (if applicable), chemical indicator results, and any issues with chemical indicator results.

Questions to ask include:

❯ Does the biological test match the type of cycle, and how often is it run? How often is the control run, and are lot numbers for both documented? What if the biological test fails?

❯ Are chemical indicators stored per the MIFU? Where should they be placed? Is the external indicator tape expired? What if the indicator fails?

❯ Can staff identify the information that must be documented for each sterilization load? Can they tell which items were sterilized?

• Immediate Use Steam Sterilization (IUSS). IUSS is a sterilization method that makes a sterilized item coming out of the sterilizer immediately available—meaning, in the shortest time possible—for use in the sterile field. According to AAMI ST79: 10.2.3, IUSS should be used only for urgent clinical situations, not for shortcuts or convenience, and the sterilized item cannot be used in, or held for, another case. The sterilizer must be tested with a biological test pack and run with a chemical indicator. Lack of an MIFU for instruments—another requirement for IUSS—is a frequent survey finding.

Questions to ask include:

❯ What are IUSS rates at the facility, and who reviews the data?

❯ What is the most common reason for IUSS?

❯ Is a tray validated for aseptic transfer being used for IUSS, as outlined in AAMI ST79?

❯ What are staff members’ experience with performing IUSS on implants?

• Decontam. Safety is of paramount concern. Personal protective equipment (PPE) is a requirement, not an option, and all staff should follow best practices for decontamination. Cleaning methods depend on the type of instruments, the use of sterilization (steam, gas, or liquid chemical), and the use of HLD or disinfectants. Brushing must occur below the surface of the water.

AAMI ST79: 6.3.3 indicates that all instruments opened in the OR or procedure room should be considered contaminated, even if they have not been used. AAMI ST79: 7.4.1 (General considerations for all devices and utensils) specifies that cloths must be clean, non-linting, and changed frequently, and that cleaning brushes should be clean, of the appropriate size and bristle type, and replaced if worn. Reusable brushes should be cleaned after each use and disinfected or sterilized at least once a day. Single-use cleaning implements (eg, single-use wipes) should be discarded after each use.

Questions to ask include:

❯ Are dirty instruments appropriately sorted, labeled, and contained? Are dirty instruments pre-treated at the point of care?

❯ Are contaminated items appropriately discarded?

❯ Are automated machines such as auto-dispensers properly calibrated and maintained?

❯ Do staff put on and take off PPE correctly? Do they know what to do when there is an incident?

• Instrument washing, washer testing. Reviewing trays as they come out of the washer can help ensure all instruments are loaded in the open position for cleaning. The washer track should be rust-free, and strainers should contain no visible debris. In addition to performing daily maintenance according to the MIFU, staff should check for stains or scales on spray arms and clean strainers at least once daily, per AAMI ST 79: 7.6.4.3.2 (Maintenance of mechanical cleaning and disinfection equipment).

AAMI ST79: 13.1 (Process monitoring, testing, and quality control, General considerations) recommends that mechanical cleaning equipment be tested at installation, each day that it is used, and after major repairs. Finally, ST79: 7.6.4.4 and 7.6.4.4.1b specify that ultrasonic cavitation testing should be performed daily when equipment is in use (MIFUs cover placement and number of tests).

Questions to ask include:

❯ How often are instrument washers tested, what tests are used, and where should they be placed in the washer?

❯ Can staff interpret test results, and where should the results be documented?

❯ Is the ultrasonic DaVinci rated? What instruments can go into it?

❯ How often is the ultrasonic cavitation tested, how many tests are used, where are they placed, and where are results documented?

• HLD. Cleaning solutions should be within the date of use and diluted correctly. Staff should check whether manual or mechanical cleaning is to be used for certain instruments. They also should test the date of the solution before each use for minimum effective concentration (MEC) with manufacturer-specific test strips. Documentation that is necessary to have includes date and time; identity of scope and accessories; method of cleaning as well as cleaning verification results; number or identifier of the processor or sterilizer as well as results of testing; identity of the processor; lot numbers of processing solutions; and more as appropriate.

HLD inspection should cover all areas, including:

❯ Admission, where alcohol, dispensers, tissues, and signage about covering coughs and wearing masks should be clearly visible.

❯ Preoperative holding and procedure rooms, where hallways should be intact, nursing stations should be clean (food at stations where specimens are handled is an Occupational Safety and Health Administration violation), and supplies should be free of stains and not expired. Staff should wear gloves when handling clean instruments. Procedure room processes should adhere to the most stringent requirements (AORN guidelines are sometimes more restrictive than AAMI’s). For example, scopes should not hang freely or touch the bottom of the cabinet. Containers for transport should be closed, leakproof, puncture-resistant, and labeled “biohazard.”

❯ Decontam. Scopes should be tested for leaks if required before manual cleaning or placement into cleaning solutions; brushes should be of the correct size and in good working order. Staff also should check that eye wash stations are functioning, that there are no damaged or stained ceiling tiles or floors, that hand hygiene is in a separate sink, that there are no fans in the room, and that staff wear clean surgical attire and head coverings (plus PPE).

Questions to ask include:

❯ Are solutions within the dates of use?

❯ What is the expiration date of test strips? Has quality assurance on been performed per MIFUs?

❯ Are the brushes disposable or reusable?

❯ How should the solution be disposed of?

Overall, Rosing says seeing with a surveyor’s eyes requires curiosity. Ask questions, he advises. Periodically audit and provide feedback. Provide training and updates to staff. Validate competencies at the moment of hiring and at least annually for high-risk / low-volume tasks. And remember to monitor everything. ORM

 

—Uyen Vo, BSN, MBA, is a freelance writer with more than 20 years of experience in healthcare.

 

References

Rosing J. Mastering Joint Commission Standards and CMS Regulations. OR Manager Conference. 2024.

The Joint Commission. Hospital Accreditation Survey Activity Guide January 2023. Joint Commission Online. December 19, 2022.

The Joint Commission. Quick Safety Issue 64: Ensuring critical instruments and devices are appropriate for reuse. February 14, 2022. Joint Commission Online.

The Joint Commission and Joint Commission Resources. Hospital Executive Briefing. September 10, 2024. [Live virtual program]

US Food & Drug Administration. Human Cell and Tissue Establishment Registration — Public Query Enter Query Criteria.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat